News Releases 2009

The following information was accurate at the time of posting, but may be superseded by subsequent disclosure.

November 30, 2009
Tekmira to Webcast Presentation at the Piper Jaffray Health Care Conference

November 12, 2009
Tekmira Announces Third Quarter 2009 Operating Results and Provides Corporate Update

November 9, 2009
Tekmira Conference Call; Third Quarter 2009 Results and Corporate Update

September 8, 2009
Tekmira to Webcast Presentation at the Rodman & Renshaw Global Investment Conference

August 12, 2009
Tekmira Announces Second Quarter 2009 Operating Results

August 7, 2009
Tekmira Conference Call Advisory - Second Quarter 2009 Operating Results and Corporate Update

August 6, 2009
Alnylam and Tekmira Participate in New Research Collaboration

July 2, 2009
Tekmira Initiates ApoB SNALP Phase 1 Clinical Trial

May 28, 2009
Tekmira Presents ApoB SNALP and PLK1 SNALP Data at Leading Scientific Conference

May 13, 2009
Tekmira Announces First Quarter 2009 Operating Results and Provides Corporate Update

May 11, 2009
Roche Partners with Tekmira to Advance RNAi Product Candidates

May 11, 2009
Tekmira Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update

May 7, 2009
Tekmira Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial

April 14, 2009
Tekmira Pharmaceuticals Files IND for ApoB SNALP

April 3, 2009
Tekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial

March 25, 2009
Tekmira Extends Research Collaboration with Bristol-Myers Squibb through 2009

March 24, 2009
Tekmira Reports 2008 Audited Results and Provides Corporate Update

March 18, 2009
Tekmira Conference Call Advisory 2008 Audited Results and Corporate Update

February 24, 2009
Tekmira Presents Data Demonstrating Further Increases in SNALP Potency

February 23, 2009
Tekmira Publishes PLK1 SNALP Anti-Tumor Efficacy Data

February 12, 2009
Tekmira Partner Alnylam Presents Data at Keystone Meeting

January 23, 2009
Tekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP

January 8, 2009
Tekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam


News Releases

News Releases 2010
News Releases 2009
News Releases 2008
News Releases 2007
News Releases 2006


Subscribe

Click here to subscribe to News Releases